{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:27:55Z","timestamp":1794965275435,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jemermed.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T22:13:19Z","timestamp":1680559999000},"page":"391-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-4032","authenticated-orcid":false,"given":"Samantha","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8876-0922","authenticated-orcid":false,"given":"Jessica","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Haroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2023.01.012_bib0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.annemergmed.2021.03.013","article-title":"Emergency department visits for nonfatal opioid overdose during the COVID-19 pandemic across six US health care systems","volume":"79","author":"Soares","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0002","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0003","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D'Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.annemergmed.2022.05.010","article-title":"Models for implementing emergency department-initiated buprenorphine with referral for ongoing medication treatment at emergency department discharge in diverse academic centers","volume":"80","author":"Whiteside","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jemermed.2019.12.034","article-title":"Management of opioid use disorder in the emergency department: a white paper prepared for the American Academy of Emergency Medicine","volume":"58","author":"Strayer","year":"2020","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0006","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0007","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health 2021. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf. Accessed September 27, 2022."},{"key":"10.1016\/j.jemermed.2023.01.012_bib0008","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.ajem.2018.02.019","article-title":"Low dose intramuscular methadone for acute mild to moderate opioid withdrawal syndrome","volume":"36","author":"Su","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0009","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.annemergmed.2018.04.007","article-title":"Identification, management, and transition of care for patients with opioid use disorder in the emergency department","volume":"72","author":"Duber","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0011","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5811\/westjem.2022.2.54681","article-title":"Attitudes on methadone utilization in the emergency department: a physician cross-sectional study","volume":"23","author":"Heil","year":"2022","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0012","unstructured":"21 CFR 1306.07, 21 CFR 1306.07 \u2013 Administering or dispensing of narcotic drugs., n.d., Code of Federal Regulations. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=1306.07. Accessed February 8, 2023."},{"key":"10.1016\/j.jemermed.2023.01.012_bib0013","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: a rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0014","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0015","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0016","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"Bruce","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0019","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0021","series-title":"Medications for opioid use disorder. For healthcare and addiction professionals, policymakers, patients, and families. Treatment Improvement Protocol TIP 63","year":"2021"},{"issue":"2","key":"10.1016\/j.jemermed.2023.01.012_bib0022","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: a systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"J Addict Dis"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108031","article-title":"One year of methadone maintenance treatment in a fentanyl endemic area: safety, repeated exposure, retention, and remission","volume":"115","author":"Stone","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/ajad.13135","article-title":"Microinduction of buprenorphine\/naloxone: a review of the literature","volume":"30","author":"Ahmed","year":"2021","journal-title":"Am J Addict"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2010.04.001","article-title":"Factors associated with complicated buprenorphine inductions","volume":"39","author":"Whitley","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"Everything is not right anymore\": buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0028","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.annemergmed.2022.05.032","article-title":"A neuropharmacological model to explain buprenorphine induction challenges","volume":"80","author":"Greenwald","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0029","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: a qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0031","first-page":"200","article-title":"Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone?","volume":"63","author":"Srivastava","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0032","series-title":"Methadone treatment for people who use fentanyl: recommendations","author":"Bromley","year":"2021"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108832","article-title":"Adapting methadone inductions to the fentanyl era","volume":"141","author":"Buresh","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-022-00299-1","article-title":"Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community","volume":"17","author":"Biondi","year":"2022","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.jemermed.2023.01.012_bib0035","unstructured":"Substance Use Philadelphia. Law enforcement: drug seizures. Available at: https:\/\/www.substanceusephilly.com\/law-enforcement. Accessed December 7, 2022."},{"key":"10.1016\/j.jemermed.2023.01.012_bib0036","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.annemergmed.2021.05.024","article-title":"Rapid adoption of low-threshold buprenorphine treatment at California emergency departments participating in the CA Bridge Program","volume":"78","author":"Snyder","year":"2021","journal-title":"Ann Emerg Med"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467923000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467923000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:50:55Z","timestamp":1760028655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467923000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0736467923000100"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2023.01.012","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}